Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Patients Say MPM Medical's Regenecare Gel Significantly Reduced the Itching and Pain of Skin Rashes Triggered by Anti-Cancer Drugs
April 18th, 2009
Patients undergoing cancer treatment reported that using Regenecare hydrogel significantly reduced the pain and itching associated with the sometimes-severe skin rashes caused by anti-cancer drugs. Conducted by the Western University of Health Sciences, the study substantiated the findings of nine previous clinical trials recognizing Regenecare for its pain-relieving and wound-healing benefits. Manufactured by MPM Medical, Inc., Regenecare is the only wound and pain management product of its kind on the market. "Pain management is one of the most-significant issues facing healthcare today," said MPM President Paul Miller. "Many patients stop or forgo...
Source: Law & Health Weekly (2009-04-18)
|
